Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06743022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CT

Study acronym: REPRO-PID
StatusRecruiting
PhaseNot applicable
Started2025-06-24
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Aug 2026 → Aug 2027
See other at-risk trials from Assistance Publique - Hôpitaux de Paris

Amendment history

2026-09-23
critical
Primary completion pushed: 2026-08 → 2027-08
Completion pushed: 2026-09 → 2027-09
2025-12-29
minor
Study Status, Oversight v3
Primary completion date2025-11→2026-08
Completion date2025-12→2026-09
2025-09-05
minor
Study Status, Sponsor/Collaborators v2
Collaborators+37 characters
URC-CIC Paris Descartes Necker Cochin
2025-07-16
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2025-05→2025-11
Completion date2025-06→2025-12
Start dateestimated 2024-12→confirmed 2025-06-24
Study sitesdetails revised at 6 of 6 sites
2024-12-16
minor
Original filing
In interstitial lung disease (ILD), the extent of ILD on chest computed tomography (CT) is recognized as an important prognostic factor. Automated tools are now available to quantify ILD, but there is a lack of data on the reproducibility of this measurement and therefore its accuracy. Therefore, the purpose of this study is to evaluate the variability of automated ILD quantification on chest CT. Reproducibility will be assessed by repeating chest CT scans and using different tools to measure the extent of disease.
Trial Details
NCT Number NCT06743022
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions Interstitial Lung Disease
Enrollment 150 participants
Start Date 2025-06-24
Primary Completion 2027-08 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-22